Literature DB >> 17149579

Influence of rectum delineation (rectal volume vs. rectal wall) on IMRT treatment planning of the prostate.

Matthias Guckenberger1, Fabian Pohl, Kurt Baier, Juergen Meyer, Oliver Koelbl, Michael Flentje, Dirk Vordermark.   

Abstract

PURPOSE: To evaluate the delineation of either the rectal volume (RV) or the rectal wall (RW) in intensity-modulated radiotherapy (IMRT) for prostate cancer: influence on dose distribution to the targets and organs at risk (OARs) was investigated.
MATERIAL AND METHODS: For ten patients with localized prostate cancer IMRT treatment plans were generated with the RV, wall including the filling, and the RW without the lumen as OAR (plan-RV and plan-RW), respectively. Two different IMRT treatment- planning systems (TPS) were utilized. The influence on target coverage and sparing of OARs was investigated.
RESULTS: No influence was seen on target coverage and sparing of the bladder and femoral heads. Doses to the RV were significantly reduced in plan-RV for all evaluated dose levels: maximum 26% and 17%, respectively, in both TPS. The dose distribution to the RW was not significantly different between plan-RV and plan-RW.
CONCLUSION: The different delineation of the OAR rectum significantly affected the inverse IMRT treatment-planning process. The use of the RV as OAR resulted in improved dose distributions to the RV. Therefore, it is suggested using the RV as OAR in IMRT treatment planning of the prostate.

Entities:  

Mesh:

Year:  2006        PMID: 17149579     DOI: 10.1007/s00066-006-1566-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  10 in total

1.  Human-computer interaction in radiotherapy target volume delineation: a prospective, multi-institutional comparison of user input devices.

Authors: 
Journal:  J Digit Imaging       Date:  2011-10       Impact factor: 4.056

2.  Dosimetric impact in the dose-volume histograms of rectal and vesical wall contouring in prostate cancer IMRT treatments.

Authors:  Laura Gómez; Carlos Andrés; Antonio Ruiz
Journal:  Rep Pract Oncol Radiother       Date:  2017-04-21

3.  Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer.

Authors:  Buelent Polat; Iris Guenther; Juergen Wilbert; Joachim Goebel; Reinhart A Sweeney; Michael Flentje; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2008-12-24       Impact factor: 3.621

4.  Evaluation of late rectal toxicity after conformal radiotherapy for prostate cancer: a comparison between dose-volume constraints and NTCP use.

Authors:  Raffaella Cambria; Barbara A Jereczek-Fossa; Federica Cattani; Cristina Garibaldi; Dario Zerini; Cristiana Fodor; Flavia Serafini; Guido Pedroli; Roberto Orecchia
Journal:  Strahlenther Onkol       Date:  2009-06-09       Impact factor: 3.621

5.  IMRT of prostate cancer: a comparison of fluence optimization with sequential segmentation and direct step-and-shoot optimization.

Authors:  Marius Treutwein; Matthias Hipp; Oliver Kölbl; Ludwig Bogner
Journal:  Strahlenther Onkol       Date:  2009-06-09       Impact factor: 3.621

6.  Impact of bladder volume on acute genitourinary toxicity in intensity modulated radiotherapy for localized and locally advanced prostate cancer.

Authors:  Arne Grün; Michael Kawgan-Kagan; David Kaul; Harun Badakhshi; Carmen Stromberger; Volker Budach; Dirk Böhmer
Journal:  Strahlenther Onkol       Date:  2018-11-15       Impact factor: 3.621

7.  Searching standard parameters for volumetric modulated arc therapy (VMAT) of prostate cancer.

Authors:  Marius Treutwein; Matthias Hipp; Oliver Koelbl; Barbara Dobler
Journal:  Radiat Oncol       Date:  2012-07-11       Impact factor: 3.481

8.  Validation of the relative insensitivity of volumetric-modulated arc therapy (VMAT) plan quality to gantry space resolution.

Authors:  Ghulam Murtaza; Stefania Cora; Ehsan Ullah Khan
Journal:  J Radiat Res       Date:  2017-07-01       Impact factor: 2.724

9.  Volumetric-modulated arc therapy and intensity-modulated radiation therapy treatment planning for prostate cancer with flattened beam and flattening filter free linear accelerators.

Authors:  Marius Treutwein; Matthias Hipp; Oliver Koelbl; Barbara Dobler
Journal:  J Appl Clin Med Phys       Date:  2017-08-30       Impact factor: 2.102

10.  Secondary malignancy risk for patients with localized prostate cancer after intensity-modulated radiotherapy with and without flattening filter.

Authors:  Marius Treutwein; Rainer Loeschel; Matthias Hipp; Oliver Koelbl; Barbara Dobler
Journal:  J Appl Clin Med Phys       Date:  2020-11-04       Impact factor: 2.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.